MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « MeshFr.i » - entrée « Antipaludiques »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antioxydants < Antipaludiques < Antiparasitaires  Facettes :

List of bibliographic references indexed by Antipaludiques

Number of relevant bibliographic references: 211.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000042 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
000044 (2021) Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis]Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000045 (2021) Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde]Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
000053 (2021) Andrew C. Berry [États-Unis] ; Russell S. Gonnering [États-Unis] ; Ivan Rodriguez [États-Unis] ; Qianying Zhang [États-Unis] ; Bruce B. Berry [États-Unis]Unfavorable hydroxychloroquine COVID-19 research associated with authors having a history of political party donations.
000055 (2021) Tuan V. Nguyen [Australie]Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
000070 (2021) Bagrat Lalabekyan [Royaume-Uni] ; Gudrun Kunst [Royaume-Uni] ; Vanessa A. Skelton [Royaume-Uni]Torsades de Pointes in Coronavirus Disease 2019 Infection.
000072 (2021) Konstantinos Parperis [Chypre (pays), États-Unis]To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
000099 (2021) Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada]The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
000118 (2021) Carlo Salvarani [Italie] ; Pamela Mancuso [Italie] ; Federica Gradellini [Italie] ; Nilla Viani [Italie] ; Paolo Pandolfi [Italie] ; Massimo Reta [Italie] ; Giuliano Carrozzi [Italie] ; Gilda Sandri [Italie] ; Gianluigi Bajocchi [Italie] ; Elena Galli [Italie] ; Francesco Muratore [Italie] ; Luigi Boiardi [Italie] ; Nicol Pipitone [Italie] ; Giulia Cassone [Italie] ; Stefania Croci [Italie] ; Anna Maria Marata [Italie] ; Massimo Costantini [Italie] ; Paolo Giorgi Rossi [Italie]Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.
000131 (2021) Carmen Magdalena Gamboa-Alonso [Mexique] ; Gabriel Figueroa-Parra [Mexique] ; Dionicio Angel Galarza-Delgado [Mexique]Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al.
000134 (2021) Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran]Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
000150 (2021) Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000170 (2021) Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal]SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases.
000175 (2021) Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen SliwaSARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000190 (2021) Dingzhong Li [République populaire de Chine] ; Jianbing Hu [République populaire de Chine] ; Dian Li [République populaire de Chine] ; Weijun Yang [République populaire de Chine] ; Shuang-Feng Yin [République populaire de Chine] ; Renhua Qiu [République populaire de Chine]Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.
000198 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
000218 (2021) Marcelo Rodrigues Dos Santos [Brésil]Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000244 (2021) Mikaela Smit [Suisse] ; Annalisa Marinosci [Suisse] ; Thomas Agoritsas [Canada] ; Alexandra Calmy [Suisse]Prophylaxis for COVID-19: a systematic review.
000316 (2021) Osaid Alser [États-Unis] ; Ava Mokhtari ; Leon Naar ; Kimberly Langeveld ; Kerry A. Breen ; Mohamad El Moheb ; Carolijn Kapoen ; Apostolos Gaitanidis ; Mathias A. Christensen ; Lydia R. Maurer ; Hassan Mashbari ; Brittany Bankhead-Kendall ; Jonathan Parks ; Jason Fawley ; Noelle Saillant ; April Mendoza ; Charudutt Paranjape ; Peter Fagenholz ; David King ; Jarone Lee ; Maha R. Farhat ; George C. Velmahos ; Haytham M A. KaafaraniMultisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Antipaludiques" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Antipaludiques" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Antipaludiques
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021